Adenocarcinoma of the Pancreas Terminated Phase 1 Trials for Temsirolimus (DB06287)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00593008Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic CancerTreatment